The authors respond [4]

Canadian Journal of Diabetes

Volumn 29, Issue 4, 2005, Pages 376-378

  Harris, Stewart B ^a,b   McFarlane, Philip ^a,c   Lank, Cynthia N ^a,d  

^a Canadian Diabetes Association 2003   (Canada)

^b WESTERN UNIVERSITY   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; THIAZIDE DIURETIC AGENT;

CANADA; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; DIABETIC NEPHROPATHY; EVIDENCE BASED MEDICINE; GOVERNMENT; HEALTH CARE COST; HEALTH CARE DELIVERY; HUMAN; HYPERTENSION; LETTER; MEDICAL SOCIETY; PRACTICE GUIDELINE;

EID: 33646684750     PISSN: 14992671     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (8)

1. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Can J Diabetes. 2003;27(suppl 2):S1-S152.
2. Romanow RJ. Building on Values. The Future of Health Care in Canada-Final Report. Ottawa, ON: Commission on the Future of Health Care in Canada; 2002. Publication CP32-85/2002E-IN. Available at: http://www.hc-sc.gc.ca/english/care/ romanow/hcc0023.html. Accessed October 31, 2005.
3. Standing Senate Committee on Social Affairs, Science and Technology. The Health of Canadians - The Federal Role. Volume Six: Recommendations for Reform. Ottawa, ON: The Senate; 2002. Available at: http://www.parl.gc.ca/37/2/parlbus/ commbus/ senate/Com-e/SOCI-E/rep-e/repoct02vol6-e.htm. Accessed October 31, 2005.
4. Vinicor F. New models of diabetes healthcare delivery. Can J Diabetes Care. 2001;25(suppl 2):24-30.
5. Harris S, Webster-Bogaert S, Lillie D, et al. A model for the dissemination of clinical practice guidelines - The Canadian Diabetes Association experience. Can J Diabetes Care. 2000;24:64-69.
6. Haynes RB, Gerstein HC. What is evidence? In: Gerstein HC, Haynes RB, eds. Evidence-based Diabetes Care. Hamilton, ON: BC Decker Inc.; 2001:1-12.
7. Harris SB, Webster-Bogaert S. Evidence-based clinical practice guidelines. In: Gerstein HC, Haynes RB, eds. Evidence-based Diabetes Care. Hamilton, ON: BC Decker Inc.; 2001:48-61.
8. Gafni A, Birch S. Inclusion of drugs in provincial drug benefit programs: Should "reasonable decisions" lead to uncontrolled growth in expenditures? CMAJ. 2003;168:849-851.